Stay updated on Subcutaneous Atezolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Atezolizumab in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The history shows multiple updates to study status and recruitment status across versions, reflecting changes in trial activity and enrollment over time.
    Difference
    0.1%
    Check dated 2025-11-03T01:16:16.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    13%
    Check dated 2025-10-05T10:05:49.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T03:11:43.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Updated to v3.0.2 (replacing v3.0.1) and removed the 'Back to Top' element.
    Difference
    0.8%
    Check dated 2025-09-13T17:40:25.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.8%
    Check dated 2025-09-06T15:25:03.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, while several location-related terms have been removed.
    Difference
    9%
    Check dated 2025-08-30T12:03:41.000Z thumbnail image

Stay in the know with updates to Subcutaneous Atezolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.